Peginterferon alfacon-1
Alternative Names: PEG INF alfacon-1; PEG-Alfacon; PEG-Infergen; PEG-interferon alfacon-1; Pegylated interferon alfacon-1Latest Information Update: 04 Oct 2006
At a glance
- Originator Amgen
- Class Antivirals; Interferons
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 13 Mar 2006 Discontinued - Phase-II for Hepatitis C in USA (SC)
- 13 Mar 2006 Discontinued - Preclinical for Hepatitis C in Canada (SC)
- 03 Jun 2005 Data presented at the Digestive Disease Week and the 106th Annual Meeting of the American Gastroenterological Association (DDW-2005) have been added to the adverse events, pharmacokinetics and Viral infections pharmacodynamics sections